Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9-Reference-Cited by-同舟云学术

Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9

Published:2011-04 Issue:4 Volume:52 Page:679-687
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Ason Brandon,Tep Samnang,Davis Jr. Harry R.,Xu Yiming,Tetzloff Glen,Galinski Beverly,Soriano Ferdie,Dubinina Natalya,Zhu Lei,Stefanni Alice,Wong Kenny K.,Tadin-Strapps Marija,Bartz Steven R.,Hubbard Brian,Ranalletta Mollie,Sachs Alan B.,Flanagan W. Michael,Strack Alison,Kuklin Nelly A.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference62 articles.

1. Thematic review series: the Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy;Steinberg;J. Lipid Res.,2006

2. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part II: the early evidence linking hypercholesterolemia to coronary disease in humans;Steinberg;J. Lipid Res.,2005

3. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia;Steinberg;J. Lipid Res.,2005

4. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I;Steinberg;J. Lipid Res.,2004

5. Role of cholesterol and lipid organization in disease;Maxfield;Nature.,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’;European Heart Journal Supplements;2022-11-12

2. Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE);Frontiers in Cardiovascular Medicine;2022-07-15

3. PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol;Mini-Reviews in Medicinal Chemistry;2018-12-06

4. Intestinal cholesterol absorption;Current Opinion in Lipidology;2018-12

5. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Efficacy and Safety in the Treatment of Hypercholesterolaemia;EMJ Diabetes;2018-11-20